Article: Slim, Flexible Stents Approved to Treat Heart Disease.

Drug-coated Xience and Promus devices are designed to keep coronary blood vessels unblocked

A new generation of drug-coated stents--the small scaffoldlike devices that hold clogged arteries open--is now available for people with coronary artery disease. The newest stents, which the Food and Drug Administration approved last week, are slimmer and more flexible than earlier models and use a different drug to inhibit the growth of scar tissue that can lead to reblockage. Illinois-based Abbott Laboratories won approval for its Xience V stent. Another company, Boston Scientific, is also offering the Abbott-manufactured stent under the brand name Promus. The companies say the ...

Related newspaper, magazine, and journal articles:

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!